VENSANA CAPITAL MANAGEMENT, LLC
VENSANA CAPITAL MANAGEMENT, LLC is a Series C+ fund in the US writing $15M–$50M checks into Healthcare, medical-devices, diagnostics, data-science, life-science-tools and tech-enabled-services.
- Stages
- Series C+
- Sectors
- Healthcare, medical-devices, diagnostics, data-science, life-science-tools, tech-enabled-services
- Check size
- $15M–$50M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2019
- Assets under management
- $1B
- Website
- vensanacap.com
Thesis
Vensana Capital is a venture capital and growth equity firm established in 2019, focused exclusively on the medtech sector. They invest in development and commercial-stage companies, aiming to improve healthcare quality and reduce costs through innovation. Their investment thesis emphasizes companies with strong clinical evidence, novel mechanisms of action, and clear paths to market adoption. Vensana Capital primarily targets the United States but may invest internationally. They typically lead or participate in financing rounds and often take active governance roles. The firm manages approximately $1 billion in AUM, with their third fund closing in January 2025 at $425 million. Their typical check size ranges from $15 million to $50 million.
Common questions
Does VENSANA CAPITAL MANAGEMENT, LLC invest at the Series C+ stage?
Yes. VENSANA CAPITAL MANAGEMENT, LLC lists Series C+ among the stages it invests in.
What check size does VENSANA CAPITAL MANAGEMENT, LLC write?
VENSANA CAPITAL MANAGEMENT, LLC writes $15M–$50M checks.
Where does VENSANA CAPITAL MANAGEMENT, LLC invest?
VENSANA CAPITAL MANAGEMENT, LLC invests in the US.